Wall Street brokerages predict that Aetna Inc (NYSE:AET) will announce $14.89 billion in sales for the current quarter, Zacks reports. Seven analysts have provided estimates for Aetna’s earnings. The highest sales estimate is $15.53 billion and the lowest is $14.30 billion. Aetna reported sales of $15.73 billion during the same quarter last year, which indicates a negative year over year growth rate of 5.3%. The company is expected to issue its next quarterly earnings results before the market opens on Tuesday, January 30th.

On average, analysts expect that Aetna will report full-year sales of $14.89 billion for the current financial year, with estimates ranging from $59.52 billion to $61.74 billion. For the next financial year, analysts expect that the business will report sales of $60.82 billion per share, with estimates ranging from $58.39 billion to $64.64 billion. Zacks Investment Research’s sales averages are an average based on a survey of research firms that cover Aetna.

Aetna (NYSE:AET) last announced its quarterly earnings data on Tuesday, October 31st. The company reported $2.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. The business had revenue of $14.99 billion for the quarter, compared to analysts’ expectations of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The firm’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same period last year, the firm posted $2.07 earnings per share.

AET has been the topic of a number of recent analyst reports. Citigroup lifted their price objective on shares of Aetna from $183.00 to $197.00 and gave the company a “buy” rating in a research note on Thursday, November 2nd. Zacks Investment Research raised shares of Aetna from a “hold” rating to a “buy” rating and set a $174.00 price objective on the stock in a research note on Thursday, October 12th. ValuEngine raised shares of Aetna from a “hold” rating to a “buy” rating in a research note on Sunday, December 31st. Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price objective on the stock. in a research note on Wednesday, December 20th. Finally, Jefferies Group lifted their price objective on shares of Aetna from $163.00 to $165.00 and gave the company a “hold” rating in a research note on Friday, October 13th. Twelve investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. Aetna presently has a consensus rating of “Buy” and a consensus price target of $172.64.

Aetna (NYSE:AET) opened at $185.10 on Thursday. The stock has a market cap of $60,360.00, a P/E ratio of 34.21, a P/E/G ratio of 1.58 and a beta of 0.61. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.53 and a quick ratio of 0.53. Aetna has a one year low of $116.04 and a one year high of $192.37.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Thursday, January 11th will be given a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.08%. Aetna’s dividend payout ratio is currently 36.97%.

Several large investors have recently modified their holdings of the company. Havens Advisors LLC acquired a new position in shares of Aetna during the fourth quarter worth $3,518,000. Schwab Charles Investment Management Inc. lifted its holdings in shares of Aetna by 2.6% during the fourth quarter. Schwab Charles Investment Management Inc. now owns 1,235,475 shares of the company’s stock worth $222,868,000 after purchasing an additional 30,799 shares during the period. Coastline Trust Co acquired a new position in shares of Aetna during the fourth quarter worth $226,000. Koshinski Asset Management Inc. lifted its holdings in shares of Aetna by 22.6% during the fourth quarter. Koshinski Asset Management Inc. now owns 10,885 shares of the company’s stock worth $1,964,000 after purchasing an additional 2,005 shares during the period. Finally, Creative Planning lifted its holdings in shares of Aetna by 9.2% during the fourth quarter. Creative Planning now owns 19,748 shares of the company’s stock worth $3,562,000 after purchasing an additional 1,666 shares during the period. Institutional investors own 87.69% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This piece was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and international copyright and trademark legislation. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/18/analysts-anticipate-aetna-inc-aet-will-announce-quarterly-sales-of-14-89-billion.html.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Get a free copy of the Zacks research report on Aetna (AET)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.